Thrombosis and Haemostasis · 1998 · 91 citations · 23 references
Life SciencesGeneticsMolecular GeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular DiseaseGene-environment InteractionGenetic RiskGenetic SusceptibilityGenotype-phenotype CorrelationLipid DisordersAtherosclerosis GeneticsGene-environment AssociationsGenotype InterpretationGenotype-phenotype Associations
The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene-environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur.
23
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Anders Hamsten, Göran Walldius, Alfred Szamosi et al. · The Lancet · 1987 · 1.5K citations
Per Eriksson, Bengt Kallin, Peter Båvenholm et al. · Proceedings of the National Academy of Sciences · 1995 · 744 citations